Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Neutralizing antibody against granulocyte/macrophage colony-stimulating factor inhibits inflammatory response in experimental otitis media.

Kariya S, Okano M, Higaki T, Makihara S, Haruna T, Eguchi M, Nishizaki K.

Laryngoscope. 2013 Jun;123(6):1514-8. doi: 10.1002/lary.23795. Epub 2012 Nov 21.

PMID:
23172593
2.

Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF.

Puljic R, Benediktus E, Plater-Zyberk C, Baeuerle PA, Szelenyi S, Brune K, Pahl A.

Eur J Pharmacol. 2007 Feb 28;557(2-3):230-5. Epub 2006 Nov 14.

PMID:
17174948
3.

Granulocyte macrophage-colony stimulating factor (GM-CSF) augments acute lung injury via its neutrophil priming effects.

Choi JC, Jung JW, Kwak HW, Song JH, Jeon EJ, Shin JW, Park IW, Choi BW, Kim JY.

J Korean Med Sci. 2008 Apr;23(2):288-95. doi: 10.3346/jkms.2008.23.2.288.

4.

Murine nucleus pulposus-derived cells secrete interleukins-1-beta, -6, and -10 and granulocyte-macrophage colony-stimulating factor in cell culture.

Rand N, Reichert F, Floman Y, Rotshenker S.

Spine (Phila Pa 1976). 1997 Nov 15;22(22):2598-601; discussion 2602.

PMID:
9399443
5.

Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.

Hesske L, Vincenzetti C, Heikenwalder M, Prinz M, Reith W, Fontana A, Suter T.

Brain. 2010 Jun;133(Pt 6):1637-54. doi: 10.1093/brain/awq081. Epub 2010 Apr 27.

PMID:
20424288
8.

Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation.

Vlahos R, Bozinovski S, Chan SP, Ivanov S, Lindén A, Hamilton JA, Anderson GP.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):34-40. doi: 10.1164/rccm.200912-1794OC. Epub 2010 Mar 4.

PMID:
20203243
9.

Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.

Wislez M, Fleury-Feith J, Rabbe N, Moreau J, Cesari D, Milleron B, Mayaud C, Antoine M, Soler P, Cadranel J.

Am J Pathol. 2001 Oct;159(4):1423-33.

10.

Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice.

Kernacki KA, Goebel DJ, Poosch MS, Hazlett LD.

Infect Immun. 1998 Jan;66(1):376-9.

11.
12.

Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.

Ishihara H, Kariya S, Okano M, Zhao P, Maeda Y, Nishizaki K.

Acta Otolaryngol. 2016 Oct;136(10):1011-6. doi: 10.1080/00016489.2016.1179786. Epub 2016 May 16.

PMID:
27181906
13.

Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.

Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):521-32. doi: 10.1164/rccm.200812-1837OC. Epub 2009 Jul 9.

PMID:
19590023
15.

Immunologic characteristics of cytokines in otitis media with effusion.

Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A.

Ann Otol Rhinol Laryngol Suppl. 1992 Oct;157:21-5.

PMID:
1416648
16.

Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.

Cicco NA, Lindemann A, Content J, Vandenbussche P, Lübbert M, Gauss J, Mertelsmann R, Herrmann F.

Blood. 1990 May 15;75(10):2049-52.

17.

Biphasic ocular inflammatory response to endotoxin-induced uveitis in the mouse.

Shen DF, Chang MA, Matteson DM, Buggage R, Kozhich AT, Chan CC.

Arch Ophthalmol. 2000 Apr;118(4):521-7.

PMID:
10766138
18.
19.

In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.

Schaafsma MR, Falkenburg JH, Landegent JE, Duinkerken N, Osanto S, Ralph P, Kaushansky K, Wagemaker G, Van Damme J, Willemze R, et al.

Blood. 1991 Oct 15;78(8):1981-7.

20.

Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.

Bosnar M, Bosnjak B, Cuzic S, Hrvacic B, Marjanovic N, Glojnaric I, Culic O, Parnham MJ, Erakovic Haber V.

J Pharmacol Exp Ther. 2009 Oct;331(1):104-13. doi: 10.1124/jpet.109.155838. Epub 2009 Jul 24.

Supplemental Content

Support Center